BACKGROUND: Radiologically characteristic ground-glass opacity (GGO) represents a special cohort of pulmonary adenocarcinomas that has been unanimously defined as biologically inert. Lymph node metastasis, however, occurs occasionally in these biologically "indolent" cancers. The incidence and underlying risk factors of nodal metastasis remain unknown. METHODS: All surgically removed GGO lesions between January 2008 and December 2014 were retrospectively reviewed from a single treatment institution. Pathologically-confirmed adenocarcinomas with systemic lymph node dissection or sampling were enrolled into the present study. All the lesions were classified into three groups according to the proportion of solid densities: group I, pure GGO; group II, 1% to 50%; and group III, 50% to 79%. Risk factor analysis of lymph node involvement was performed by multivariate logistic regression. RESULTS: Of the 867 patients eligible for this study, 553 (63.7%) presented as pure GGOs (Group I) and 314 (36.2%) were mixed GGOs, of which 160 (18.5%) were in group II and 154 (17.8%) in group III. Lymph node metastasis was confirmed in 25 patients, among these 25 cases, 11 (11/160) were group II and 14 (14/154) were group III; two of the 25 patients died from lung cancer metastases at their postoperative 23(rd) and 36(th) month, respectively. Statistical analysis revealed three predictors for lymph nodal metastasis: tumor size, preoperative serum carcinoembryonic antigen level and proportion of the mix density. CONCLUSIONS: A larger size, mixed GGOs with a higher proportion of solid component, and elevated serum CEA level were associated with a higher preference for nodal metastasis.
BACKGROUND: Radiologically characteristic ground-glass opacity (GGO) represents a special cohort of pulmonary adenocarcinomas that has been unanimously defined as biologically inert. Lymph node metastasis, however, occurs occasionally in these biologically "indolent" cancers. The incidence and underlying risk factors of nodal metastasis remain unknown. METHODS: All surgically removed GGO lesions between January 2008 and December 2014 were retrospectively reviewed from a single treatment institution. Pathologically-confirmed adenocarcinomas with systemic lymph node dissection or sampling were enrolled into the present study. All the lesions were classified into three groups according to the proportion of solid densities: group I, pure GGO; group II, 1% to 50%; and group III, 50% to 79%. Risk factor analysis of lymph node involvement was performed by multivariate logistic regression. RESULTS: Of the 867 patients eligible for this study, 553 (63.7%) presented as pure GGOs (Group I) and 314 (36.2%) were mixed GGOs, of which 160 (18.5%) were in group II and 154 (17.8%) in group III. Lymph node metastasis was confirmed in 25 patients, among these 25 cases, 11 (11/160) were group II and 14 (14/154) were group III; two of the 25 patients died from lung cancer metastases at their postoperative 23(rd) and 36(th) month, respectively. Statistical analysis revealed three predictors for lymph nodal metastasis: tumor size, preoperative serum carcinoembryonic antigen level and proportion of the mix density. CONCLUSIONS: A larger size, mixed GGOs with a higher proportion of solid component, and elevated serum CEA level were associated with a higher preference for nodal metastasis.
Entities:
Keywords:
Ground-glass opacity (GGO); lymph node metastasis; non-small-cell lung cancer
Authors: David M Hansell; Alexander A Bankier; Heber MacMahon; Theresa C McLoud; Nestor L Müller; Jacques Remy Journal: Radiology Date: 2008-01-14 Impact factor: 11.105
Authors: Hyun Ju Lee; Jin Mo Goo; Chang Hyun Lee; Chang Min Park; Kwang Gi Kim; Eun-Ah Park; Ho Yun Lee Journal: Eur Radiol Date: 2008-10-17 Impact factor: 5.315
Authors: J H Austin; N L Müller; P J Friedman; D M Hansell; D P Naidich; M Remy-Jardin; W R Webb; E A Zerhouni Journal: Radiology Date: 1996-08 Impact factor: 11.105
Authors: Jong Ho Cho; Yong Soo Choi; Jhingook Kim; Hong Kwan Kim; Jae Ill Zo; Young Mog Shim Journal: Ann Thorac Surg Date: 2014-11-15 Impact factor: 4.330
Authors: Luis Callol; Francisco Roig; Alfredo Cuevas; Jose Ignacio de Granda; Francisco Villegas; Javier Jareño; Eva Arias; Jose M Albiach Journal: Lung Cancer Date: 2007-02-20 Impact factor: 5.705
Authors: Marcello Migliore; Mariaconcetta Fornito; Manuela Palazzolo; Alessandra Criscione; Mariapia Gangemi; Francesco Borrata; Paolo Vigneri; Marco Nardini; Joel Dunning Journal: Ann Transl Med Date: 2018-03